Tech Company CollectionsBiotechnology Companies
List of Biotechnology Companies
or search all companiesSelect...
Select...
Loading...
Page 1 of NaN
Displaying companies
Ouroboros Medicines is a biotechnology company that specializes in immunology and focuses on treating long-term immune-mediated illnesses. The company addresses chronic immune-mediated conditions directly by integrating scientific knowledge, a proven histo | San Francisco | CA | 20 - 50 | 2025 | $120,000,000 |
Tenvie Therapeutics is a biotechnology company founded to improve patients' lives with neurological, cardiometabolic, and ophthalmic diseases. The company is focused on developing small molecules targeting brain inflammation, metabolic dysfunction, and lys | San Francisco | CA | 20 - 50 | 2025 | $200,000,000 |
Ambrosia Biosciences offers drug development services for small molecule-based therapies for obesity and other metabolic disorders. | Boulder | CO | 20 - 50 | 2024 | $41,000,000 |
Alys Pharmaceuticals engages in immuno-dermatology services. The company is reshaping the treatment landscape through advanced scientific innovations and a strong research and development-focused multi-platform pipeline. Alys emerged as a result of the str | Boston | MA | 10 - 50 | 2024 | $100,000,000 |
Bambusa Therapeutics operates as biotechnology company, that focuses on developing bispecific antibodies. | 10 - 50 | 2024 | $105,000,000 | ||
VisiRose offers an innovative approach to treating infectious keratitis and other eye diseases. | Knoxville | TN | 2 - 10 | 2024 | $3,000,000 |
Timberlyne Therapeutics is a clinical-stage biopharmaceutical company that develops and commercializes revolutionary medicines for autoimmune illnesses. The company utilizes its team's experience in drug development to secure top-tier assets focused on pro | San Diego | CA | 10 - 50 | 2024 | $180,000,000 |
Navigator Medicines operate as a biotech company that leads the advancement of biologics for targeted immune regulation & restoration. | Scotch Plains | NJ | 5 - 20 | 2024 | $100,000,000 |
Jade Biosciences is developing transformative therapies to redefine the standard of care for inflammation and immunology indications. | Waltham | MA | 4 | 2024 | $602,600,000 |
K-Scale Labs is a robotic engineering company specializing in creating open-source humanoid robots. | New York | NY | 2 - 10 | 2024 | $500,000 |
DeltaGen is an enterprise AI company transforming buyside M&A by automating 80% of manual workflows—eliminating inefficiencies and accelerating deal velocity for corporate development teams, private equity firms, and strategic acquirers. Unlike traditional | 50 - 268 | 2024 | $2,700,000 | ||
Developing innovative therapeutics to materially improve the lives of patients. We strive to be transparent and open in our goals, plans, and progress. | San Diego | CA | 20 - 50 | 2024 | $370,000,000 |
GEMMABio is a therapeutics company that supports the rare disease community. | Philadelphia | PA | 50 - 100 | 2024 | $34,000,000 |
Cradle is a cryonics company that develops and proves the feasibility of human organs and whole-body reversible cryopreservation. That aims to focus on pausing and restarting biological functions through freezing to prevent tissue damage in dead bodies. | San Francisco | CA | 20 - 50 | 2024 | $48,000,000 |
Seaport Therapeutics operates as a clinical stage biopharmaceutical company. | Boston | MA | 20 - 100 | 2024 | $325,000,000 |
nChroma Bio's integrated product engine allows for safe, accurate, and targeted in vivo administration, addressing major shortcomings of current genetic medicine techniques. | Boston | MA | 50 - 100 | 2024 | $75,000,000 |
Mirador Therapeutics envisions precision medicine for immune-mediated inflammatory and fibrotic diseases. | San Diego | CA | 20 - 50 | 2024 | $480,000,000 |
Eyconis, Inc. is a privately held, pre-clinical stage biopharmaceutical company focused on transforming the ophthalmology treatment paradigm through the development, manufacture, and commercialization of novel, best-in-class therapeutics for eye diseases. | 10 - 50 | 2024 | $85,251,248 | ||
Chai Discovery creates Chai-1, a multi-modal foundation model designed for predicting molecular structures relevant to drug discovery. The model facilitates the unified prediction of proteins, small molecules, and nucleic acids, and is available for free f | San Francisco | CA | 5 - 20 | 2024 | $101,000,000 |
Nura Health is a molecular diagnostics company whose mission is to advance women's health through the development and delivery of novel practice-changing non-invasive tests. We prioritize innovative, evidence-based diagnostic methods enhanced by AI & Machi | 1 - 10 | 2024 | |||
Kailera Therapeutics is a clinical-stage biotechnology company that provides revolutionary therapies for treating obesity and related diseases. | Waltham | MA | 50 - 200 | 2024 | $1,000,000,000 |
Jupiter Endovascular is a medical technology start-up. Its mission is to cover the entire spectrum of cardiovascular illness, seeing compelling potential to reinvent treatments for millions of people. | Menlo Park | CA | 10 - 50 | 2024 | $21,000,000 |
Trace Neuroscience is a biopharmaceutical company that aims to extend the promise of genetic medicine to patients with neurodegenerative illnesses. | South San Francisco | CA | 10 - 50 | 2024 | $101,000,000 |
Converge Bio is at the forefront of integrating Generative AI with biological data. Our mission is to empower biotech and pharmaceutical companies to discover and develop more effective drugs faster, utilizing the power of Large Language Models (LLMs) spec | Wilmington | DE | 20 - 50 | 2024 | $5,500,000 |
Xaira Therapeutics is an integrated biotechnology company driving advances in artificial intelligence to learn the language of life and transform how we treat disease. The company seeks to rethink the drug discovery and development process from end-to-end | San Francisco | CA | 50 - 200 | 2024 | $1,000,000,000 |
GondolaBio is a clinical-stage biopharmaceutical company focused on developing next-generation therapeutics for genetic diseases. Originally launched as BridgeBioX, a subsidiary of BridgeBio, GondolaBio secured $300M in private financing from external inve | 20 - 100 | 2024 | $300,000,000 | ||
Kivu Bioscience is a biotech company developing next-generation antibody-drug conjugates to deliver best-in-class therapeutics and focused on rapidly advancing next generation transformative assets. | San Francisco | CA | 5 - 20 | 2024 | $92,000,000 |
Newleos Therapeutics is a biotech startup dedicated to producing safer and more effective neuroscience medicines. | 10 - 50 | 2024 | $93,500,000 | ||
Eris Biotech is a biotech company that developing hypoxia-activated prodrugs (HAPs) for the treatment of solid tumors. | American Fork | UT | 2 - 10 | 2023 | $500,000 |
Junevity is a biotech rewinding complex metabolic disease. Based on 6 years of breakthrough research at UCSF, Junevity's REWIND platform identifies high-level regulators of metabolic disease with known pharmacological pathways. Junevity is advancing multip | 5 - 20 | 2023 | $10,000,000 | ||
Retension Pharmaceuticals is developing RTN-001, a differentiated, tissue-targeted PDE5 inhibitor that has been optimized for the treatment of uncontrolled hypertension. RTN-001 has been evaluated in over 265 subjects across 9 clinical trials. In these stu | Falls Church | VA | 2 - 10 | 2023 | $25,400,000 |
We are Montara Therapeutics, a San Francisco-based precision-medicine neuroscience biotech startup. Our team boasts significant experience from successful biotech firms such as Mitokinin, Denali, and Soteria, supported by a world-class Scientific Advisory | San Francisco | CA | 20 - 50 | 2023 | $31,300,000 |
Tern Therapeutics develops transformative, one-time genetic treatments for rare diseases. | 2 - 10 | 2023 | $15,000,000 | ||
Predicta Biosciences is a precision oncology firm that integrates multiomics and liquid biopsies to create diagnostic tools and therapies. They also have an in-house pipeline for novel immunotherapy targets in pre-clinical stages. | Boston | MA | 5 - 10 | 2023 | $28,600,000 |
Spyre Therapeutics combines best-in-class antibody engineering, rational therapeutic combinations, and precision immunology approaches to maximize efficacy, safety, and convenience of treatments for inflammatory bowel disease. | San Francisco | CA | 87 | 2023 | $1,100,999,936 |
Granza Bio is a company that developing cancer therapies based on human body's immune system. | San Francisco | CA | 2 - 10 | 2023 | $7,640,000 |
Doron Therapeutics is a clinical-stage biotechnology company that has developed intra-articular biologic drugs derived from placental tissue and consistently delivers a host of beneficial growth factors with potent anti-inflammatory, tissue-protective, and | Chapel Hill | NC | 5 - 10 | 2023 | $11,000,000 |
SynsoryBio is a biotechnology research company that offers next-generation protein therapeutics services. | Somerville | MA | 1 - 10 | 2023 | $500,000 |
DANNCE is a deep learning solution to automate behavioral analysis for drug development and disease diagnosis. Our platform takes patient video as input and uses our proprietary 3-D pose tracking and behavioral analysis algorithms to quantify behavior. DA | Boston | MA | 5 - 10 | 2023 | $2,600,000 |
Avenue Biosciences is pioneering the future of biotechnology, with a mission to transform the development of protein biologics for healthcare advancements. Our cutting-edge, high-throughput engineering platform transforms the production of protein biologic | Palo Alto | CA | 10 - 50 | 2023 | $2,500,000 |
EvolutionaryScale is a developer of biological artificial intelligence models for therapeutic design. The business predicts protein structures by combining biological data from DNA sequences, gene expression, and epigenetic states, allowing scientists to u | New York | NY | 20 - 50 | 2023 | $142,000,000 |
Brightstar Therapeutics is a biotechnology company focused on innovative treatment options that improve clinical outcomes and quality of life for people living with corneal and ocular surface diseases. | Lexington | KY | 5 - 10 | 2023 | |
NeuroBionics is pioneering the future of precision bioelectronic medicine by inventing the next generation of implanted devices that will seamlessly interface with the human body. | Seattle | WA | 5 - 20 | 2023 | $11,000,000 |
Sealonix focuses on the development and commercialization of hemostatic sealants using its proprietary biomaterials. Sealonix is working on a sealant patch that will provide quick hemostasis for abdominopelvic and orthopedic operations. The PramStat patch | Bedford | MA | 2 - 10 | 2023 | $20,000,000 |
Nanograb is a computational drug discovery company that uses AI to generate the best combination of binders to treat different diseases. | San Francisco | CA | 5 - 10 | 2023 | $500,000 |
Edgewood Oncology is a clinical-stage biotechnology business established to fulfill the potential of BTX-A51 for patients with solid tumors that are genetically specified and hematologic malignancies. Our goal is to create a novel treatment that will prolo | Brookline | MA | 2 - 10 | 2023 | $20,000,000 |
Valora Therapeutics is a biotechnology company that provides engineering of chimeric antibodies . | Los Angeles | CA | 5 - 20 | 2023 | $30,000,000 |
Biostate AI develops generative AI that benefit all human health. | Palo Alto | CA | 20 - 50 | 2023 | $16,000,000 |
Kardigan is a patient-driven heart health firm that is revolutionizing cardiovascular drug development to produce medicines that take patients from symptom management to functional cures. | South San Francisco | CA | 10 - 200 | 2023 | $554,000,000 |
Velorum Therapeutics produces powerful cancer treatments that starve tumors. | South San Francisco | CA | 1 - 10 | 2023 | $500,000 |
Pi Health is a provider of platforms to assist oncology-related clinical trials with identifying sites and helping sponsors manage sites | Cambridge | MA | 50 - 100 | 2023 | $30,877,444 |
Pranax is a software company currently based in Pinehurst, Texas, United States. It has been founded in 2023. | Pinehurst | TX | 2 - 10 | 2023 | $10,000,000 |
Amplifyer Bio is a biotechnology research company that develops technology of transformative potential for the liquid biopsy field. | Lexington | MA | 5 - 10 | 2023 | $7,078,494 |
TwoStep Therapeutics is developing novel tumor-targeting therapeutics for solid tumors. | Palo Alto | CA | 5 - 10 | 2023 | $6,500,000 |
Biogenesis is building the end-to-end platform for clinical research. | Palo Alto | CA | 5 - 20 | 2023 | $2,750,000 |
Mach5 Therapeutics is a biotechnology company. | Atlanta | GA | 1 - 10 | 2023 | $23,354,508 |
About HAPPY POTATO - Perfect Fries ! The world's best Flavored French Fries ! Feel the Flavor with everyone's favorite French fries Products Flavoring Perfect Fries | 10 - 100 | 2023 | $7,693,035 | ||
Speeding lifesaving cures with AI-driven design & real-time insights for faster, intuitive clinical development & patient access. | Boston | MA | 5 - 20 | 2023 | $7,000,000 |
Crop Diagnostix is a biotechnology company that uses RNA sequencing and AI for predictive agriculture. | San Diego | CA | 5 - 10 | 2023 | $3,577,993 |
Shinobi Therapeutics focuses on creating hypoimmune CD8αβ iPS-T cells that work with the immune system to treat cancer and other diseases. The company utilizes advanced immune evasion technology to enhance the effectiveness and accessibility of cell therap | South San Francisco | CA | 20 - 50 | 2023 | $178,000,000 |
Taxa is a synthetic microbiome company sculpting the skin microbiome using genetic engineering technologies such as CRISPR/spCas9. | San Francisco | CA | 2 - 10 | 2023 | $2,500,000 |
Attovia Therapeutics is a biotherapeutics pipeline developer focused on immune-mediated illness and oncology. The company uses the nanobody platform to create tiny format binders with low picomolar affinity, increased selectivity, quicker internalization, | Fremont | CA | 20 - 50 | 2023 | $255,000,000 |
Olio Labs utilizes AI for combo therapeutics, optimizing and minimizing side effects through automated discovery of protein interactions. | CA | 5 - 10 | 2023 | $8,700,000 | |
Caladan Bio specializes in next-generation bioreactors, offering modular, affordable, and cutting-edge solutions. | New York | NY | 2 - 10 | 2023 | $5,100,000 |
Peregrine Health is a healthcare company formed by Integrative Life Network (ILN) and Integrative Health Centers. | Nashville | TN | 20 - 50 | 2023 | $13,514,671 |
Primrose Bio is a biotech company that focuses on discovery, development, and manufacturing of new molecules. innovative therapeutics, vaccines and ingredients to aevance global health. | San Diego | CA | 50 - 100 | 2023 | $16,489,924 |
Kincell Bio collaborates with cell therapy developers by using considerable scientific experience and industry understanding. Transparency, accountability, and accuracy are essential to what makes us a reliable partner for process and analytical developmen | Gainesville | FL | 20 - 100 | 2023 | $58,000,000 |
Long Description: Aiolos Bio is a biotech company focused on developing therapies for respiratory diseases like asthma as well as other immune conditions. The company is initially focused on advancing AIO-001, a monoclonal antibody therapy for moderate-to- | San Francisco | CA | 20 - 50 | 2023 | $245,000,000 |
ParcelBio is a company that creating a programmable method for safely and precisely delivering mRNA to many cell types in the body. | San Francisco | CA | 5 - 10 | 2023 | $500,000 |
CrossBridge Bio operates as a biotechnology company, innovates ADC therapeutics through stable dual linker payload technology. | 5 - 10 | 2023 | $10,000,000 | ||
BiomEdit is an innovation company that discovers, designs, and develops novel probiotics, microbiome derived bioactives, and engineered microbial medicines to address unmet needs in animal health. Our ambition is to create solutions to some of the most imp | Fishers | IN | 20 - 50 | 2022 | $66,900,000 |
Wild Microbes is a next-generation microbial platform that makes everything from plastics to proteins. They develop new microbial strains, making scaling sustainable products faster and cheaper than ever. | Cambridge | MA | 2 - 10 | 2022 | $3,300,000 |
OverT Bio operates as a biotech company that provide cell therapy for cancers.. The company's cell therapies identify and develop novel genetic modifications that will help immune cells overcome barriers created by tumors and lead to effective and durable | New York | NY | 2 - 10 | 2022 | $16,120,000 |
Xellar Biosystems is a wet artificial intelligence biotechnology company that provides analysis of drug testing and treatment. | Newton | MA | 20 - 50 | 2022 | 100000000 CNY |
Artera is a provider of precision medicine and develops artificial intelligence (AI) testing to customize treatments for cancer patients. It develops specialized tools to support personalized clinical care. Its test predicts therapeutic benefits and provid | Los Altos | CA | 50 - 200 | 2022 | $110,000,000 |
InduPro is a biotechnology company that specializes in protein therapeutics and cell-surface platform technologies. | Seattle | WA | 10 - 50 | 2022 | $85,000,000 |
Insamo offers the discovery of membrane-permeable & orally available cyclic-peptides which lies in its automated process of designing, synthesizing, and testing at an unprecedented scale. | Berkeley | CA | 10 - 50 | 2022 | $12,000,000 |
Uniquity Bio operates as a drug development company. | Malvern | PA | 10 - 50 | 2022 | $300,000,000 |
Metsera operates as a clinical-stage biopharmaceutical company. | New York | NY | 50 - 100 | 2022 | $505,000,000 |
Omnipulse Biosciences offers single injection quantities suitable for clinical trials and commercial distribution to low-income countries | Cambridge | MA | 2 - 10 | 2022 | $6,999,999 |
IDRx is a clinical-stage biopharmaceutical company dedicated to transforming cancer care with intelligently designed precision combination therapies. IDRx is headquartered in Plymouth, Massachusetts and was founded in 2022. | Plymouth | MA | 20 - 50 | 2022 | $242,550,000 |
Diagonal Therapeutics is a biotechnology startup that is pioneering a novel technique to finding and producing agonist antibodies. Diagonal Therapeutics platform combines novel computational and experimental methodologies to solve the traditional obstacles | Cambridge | MA | 20 - 50 | 2022 | $128,000,000 |
Eascra Biotech creates Janus base nanomaterials based on DNA nanotechnology that are highly effective and super biocompatible for articular cartilage, central nervous system disorders, solid tumors, and other chronic conditions. Its three generations of DN | Boston | MA | 2 - 10 | 2022 | $2,174,990 |
Remepy is biotechnology research pioneering hybrid drugs. The company believes that in the future, software applications will become an integral part of treatments offered by Pharma companies in the form of Hybrid Drugs. These will include both a software | 20 - 100 | 2022 | $15,000,000 | ||
Visiox is a privately funded biopharmaceutical company focused on the development and commercialization of ophthalmic therapeutic candidates to address highly prevalent diseases in need of new treatment options. | Tarrytown | NY | 2 - 10 | 2022 | $7,000,000 |
Cisterna Biologics is a technology company that aims to solve the biotech industry's main challenges in developing mRNA-based therapeutics. Cisterna Biologics uses proprietary technologies to build the next generation of mRNA. | Carlsbad | CA | 1 - 10 | 2022 | $500,000 |
Amplexd Therapeutics focuses on the development of non-invasive, topical treatments aimed at addressing HPV-induced cervical dysplasia, a precursor to cervical cancer. The company's mission centers on providing accessible solutions to combat this public he | Gaithersburg | MD | 2 - 10 | 2022 | $2,000,000 |
Vibe Bio is a community of patients, scientists, and partners committed to identifying, funding and developing promising treatments to rare diseases and empowering patient communities with unprecedented ownership over the process.Join us | Boston | MA | 5 - 20 | 2022 | $12,000,000 |
Firefly Bio specializes in Degrader Antibody Conjugates (DACs) which combine the unique strengths of ADCs with selective protein degraders. | San Francisco | CA | 20 - 50 | 2022 | $94,000,000 |
FORAY bioscience is a biotechnology company that uses biomanufacturing techniques to produce wood products. | Cambridge | MA | 5 - 10 | 2022 | $3,413,246 |
Maverick BioMetals is a biotechnology business that is working to improve lithium processing. Founded in 2022 and is based in San Francisco, CA. | San Francisco | CA | 5 - 10 | 2022 | $10,143,534 |
Integrated Biosciences, Inc. is a biotechnology company. The Company combines synthetic biology and machine learning to develop next-generation therapeutics for age-related diseases. Integrated Biosciences operates in the United States. | 10 - 50 | 2022 | $17,200,000 | ||
DEM Bio is pioneering the next generation of immunotherapeutics that unleash macrophages and immune phagocytes to eliminate tumors by targeting ‘Don’t eat me’ (DEM) and ‘Eat me’ (EM) signals on cancer cells and macrophages. Founded by Longwood Fund and is | Cambridge | MA | 20 - 50 | 2022 | $70,000,000 |
Stellaromics is a biotechnology company that specializes in 3D in situ multi-omic analysis technology. | Boston | MA | 20 - 50 | 2022 | $105,000,000 |
Panome Bio can help you profile and discover biomarkers with our Next-Generation Metabolomics capabilities, comprehensive workflows and personalized data analysis reports. Our Next-Generation Metabolomics platform is making major advancements in the metabo | St. Louis | MO | 10 - 50 | 2022 | $11,973,835 |
Founded by Flagship Pioneering, Empress re-imagines the process of small molecule drug discovery. Our bioplatform harnesses the power of evolution, human molecular and genetic data, and artificial intelligence to focus on endogenous sources of inherently d | Cambridge | MA | 20 - 50 | 2022 | $50,000,000 |
Apogee Therapeutics, Inc. is a biotechnology company advancing novel therapies to address patients’ needs. Based in San Francisco and backed by leading life sciences funds, the company expects its lead pipeline program to enter clinical trials in 2023. | San Francisco | CA | 196 | 2022 | $997,000,000 |
Many diseases, including cancer and monogenic diseases, are often caused by specific proteins that are abnormally degraded and lost from the cell. In cancer, protective tumor suppressors are aberrantly destroyed, allowing cancer cells to circumvent cell de | San Francisco | CA | 20 - 50 | 2022 | $65,000,000 |
Areteia Therapeutics is a new biotechnology company committed to putting asthma patients in better control of their disease—and back in control of their lives—with the first potential oral drug for eosinophilic asthma. | Chapel Hill | NC | 10 - 50 | 2022 | $425,000,000 |
NewLimit specializes in treating age-related diseases to extend the human health span. It works on developing epigenetic reprogramming medicines to treat diseases with large unmet needs. | South San Francisco | CA | 10 - 50 | 2022 |
Loading...
Everything You Need, One Platform.
From job listings to startups, investors to funding rounds, and everything in between, Employbl puts the power in your hands. Why wait?
Start your free trial today!Stay Ahead of the Curve
Sign up for our newsletter to stay informed about the latest startups and trends in the tech market. Let Employbl be your guide to success.